These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9218585)

  • 1. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
    Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
    J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
    Zanelli E; Krco CJ; David CS
    J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
    Monji T; McCormack AL; Yates JR; Pious D
    J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
    Kwok WW; Nepom GT; Raymond FC
    J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries.
    Volz T; Schwarz G; Fleckenstein B; Schepp CP; Haug M; Roth J; Wiesmüller KH; Dannecker GE
    Hum Immunol; 2004 Jun; 65(6):594-601. PubMed ID: 15219379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection.
    Godkin AJ; Davenport MP; Willis A; Jewell DP; Hill AV
    J Immunol; 1998 Jul; 161(2):850-8. PubMed ID: 9670963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
    Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
    Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
    Nepom BS; Nepom GT; Coleman M; Kwok WW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
    Buckner J; Kwok WW; Nepom B; Nepom GT
    J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
    Suri A; Walters JJ; Gross ML; Unanue ER
    J Clin Invest; 2005 Aug; 115(8):2268-76. PubMed ID: 16075062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
    J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
    Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
    Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
    Wu S; Gorski J; Eckels DD; Newton-Nash DK
    J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
    Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
    J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library.
    Jüse U; van de Wal Y; Koning F; Sollid LM; Fleckenstein B
    Hum Immunol; 2010 May; 71(5):475-81. PubMed ID: 20105447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis.
    Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY
    Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.